1. Home
  2. LEGN vs UBSI Comparison

LEGN vs UBSI Comparison

Compare LEGN & UBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • UBSI
  • Stock Information
  • Founded
  • LEGN 2014
  • UBSI 1982
  • Country
  • LEGN United States
  • UBSI United States
  • Employees
  • LEGN N/A
  • UBSI N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • UBSI Major Banks
  • Sector
  • LEGN Health Care
  • UBSI Finance
  • Exchange
  • LEGN Nasdaq
  • UBSI Nasdaq
  • Market Cap
  • LEGN 6.7B
  • UBSI 5.4B
  • IPO Year
  • LEGN 2020
  • UBSI N/A
  • Fundamental
  • Price
  • LEGN $33.11
  • UBSI $37.43
  • Analyst Decision
  • LEGN Strong Buy
  • UBSI Hold
  • Analyst Count
  • LEGN 12
  • UBSI 3
  • Target Price
  • LEGN $73.36
  • UBSI $40.50
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • UBSI 519.5K
  • Earning Date
  • LEGN 11-11-2025
  • UBSI 10-23-2025
  • Dividend Yield
  • LEGN N/A
  • UBSI 3.95%
  • EPS Growth
  • LEGN N/A
  • UBSI 7.20
  • EPS
  • LEGN N/A
  • UBSI 2.84
  • Revenue
  • LEGN $796,838,000.00
  • UBSI $1,071,104,000.00
  • Revenue This Year
  • LEGN $70.75
  • UBSI $22.13
  • Revenue Next Year
  • LEGN $52.47
  • UBSI $4.54
  • P/E Ratio
  • LEGN N/A
  • UBSI $13.20
  • Revenue Growth
  • LEGN 74.75
  • UBSI 5.86
  • 52 Week Low
  • LEGN $27.34
  • UBSI $30.51
  • 52 Week High
  • LEGN $52.31
  • UBSI $44.43
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 36.16
  • UBSI 47.71
  • Support Level
  • LEGN $33.20
  • UBSI $37.63
  • Resistance Level
  • LEGN $34.71
  • UBSI $38.12
  • Average True Range (ATR)
  • LEGN 1.22
  • UBSI 0.60
  • MACD
  • LEGN -0.09
  • UBSI -0.11
  • Stochastic Oscillator
  • LEGN 10.96
  • UBSI 10.64

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About UBSI United Bankshares Inc.

United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services.

Share on Social Networks: